Last update: November 19th 2014
November 14th 2014

WHO Statement on Public Disclosure of Clinical...

The International Society of Drug Bulletins (ISDB), Medicines in Europe Forum (MiEF), Health Action International (HAI) Europe, Nordic Cochrane Centre (NCC) and Public Citizen submitted this joint response to the WHO public consultation on public disclosure of clinical...

October 22th 2014

Medicines are not just a commodity

Medicines are not just a commodity: the International Society of Drug Bulletins (ISDB), the Medicines in Europe Forum (MiEF) and the Nordic Cochrane Centre (NCC) welcome the decision to leave responsibility for medicinal products with Health Commissioner (joint press...

October 16th 2014

EMA’s final policy on access to clinical data:...

On 2 October 2014, the European Medicines Agency (EMA) finally adopted its policy on access to clinical data. From 1 January 2015 onwards, the general public will be able to “view on screen” selected parts of trial reports submitted in support of marketing authorisations, and...

September 23th 2014

New EU Clinical Trials Regulation: a major...

Joint briefing paper by 7 organisations. The major advance in transparency brought by the adoption of the EU regulation on clinical trials needs to be preserved from neutralisation by industry lobbies.

for members only

NEWSLETTER

2014

March 03th 2014

March


ISDB Publications

Manuals & booklets

October 01th 2008

ISDB Booklet

ISDB Information Booklet
Independence from drug companies is a key element of our policy

booklet october 2008 english (639 KB) - spanish (624 KB)

ISDB - International Society of Drug bullettins

Contact details:
President: president@isdbweb.org
Webmaster: maria.font@ulss20.verona.it

© 2014